Thu, Jan 29, 2015, 12:45 AM EST - U.S. Markets open in 8 hrs 45 mins

Recent

% | $
Quotes you view appear here for quick access.

Dendreon Corporation Message Board

  • ducttapesolder ducttapesolder Apr 29, 2013 5:53 PM Flag

    Provenge Clinical Trials - 19 of them

    There are currently 11 studies involving Sipuleucel-T that are getting underway. 8 of those are actively recruiting, the other 3 should be starting soon. 4 of these studies are not sponsored by DNDN. 1 of the studies that is recruiting is related to Europe Manufacturing QA/QC. In addition to the 11 above there are 8 more that are active that are not recruiting patients. That is 19 studies in total.

    I think if the drug was a dud, there wouldn't be so much interest in looking it how it works, why it works, if it works better with other cancer meds or by itself, if it is also safe in EU and so forth and so on.

    The treatment works and they are trying to figure out why and how to make it work better.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DNDN
0.1270.000(0.00%)Nov 18 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Exelixis, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
QUALCOMM Incorporated
NASDAQWed, Jan 28, 2015 4:00 PM EST